Taken together, the present study demonstrates that matrine therapy inhibits the development and progression of CRC cells by controlling cell proliferation, apoptosis, cell migration, and the cell cycle by downregulating Erlin1 expression. Here, ERLIN1 is linked to colorectal carcinoma.